Intellia Therapeutics IncNASDAQ:NTLA
- LAST PRICE21.3800
- TODAY'S CHANGE (%)-0.7200 (-3.2579%)
- Bid / Lots21.3300/ 4
- Ask / Lots21.6800/ 1
- Open / Previous Close22.3300 / 22.1000
- Day Range
- 52 Week Range
- Volume1,946,671
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NTLA |
|---|---|---|
| 09:32 ET | 12699 | 22.19 |
| 09:34 ET | 1150 | 22.21 |
| 09:36 ET | 5612 | 22.23 |
| 09:38 ET | 6373 | 22.26 |
| 09:39 ET | 7656 | 22.35 |
| 09:41 ET | 4029 | 22.37 |
| 09:43 ET | 19783 | 22.4 |
| 09:45 ET | 2647 | 22.44 |
| 09:48 ET | 1876 | 22.41 |
| 09:50 ET | 3434 | 22.45 |
| 09:52 ET | 2857 | 22.42 |
| 09:54 ET | 3669 | 22.38 |
| 09:56 ET | 5885 | 22.41 |
| 09:57 ET | 5850 | 22.245 |
| 09:59 ET | 3025 | 22.15 |
| 10:01 ET | 3679 | 22.04 |
| 10:03 ET | 4182 | 22.01 |
| 10:06 ET | 2184 | 21.95 |
| 10:08 ET | 12138 | 21.88 |
| 10:10 ET | 6809 | 21.75 |
| 10:12 ET | 16972 | 21.7 |
| 10:14 ET | 5694 | 21.7 |
| 10:15 ET | 4052 | 21.72 |
| 10:17 ET | 3862 | 21.849 |
| 10:19 ET | 4132 | 21.82 |
| 10:21 ET | 13797 | 21.93 |
| 10:24 ET | 48137 | 22.11 |
| 10:26 ET | 3620 | 22.09 |
| 10:28 ET | 978 | 22.1 |
| 10:30 ET | 2270 | 22.04 |
| 10:32 ET | 2475 | 22.05 |
| 10:33 ET | 3606 | 22.04 |
| 10:35 ET | 4058 | 22.015 |
| 10:37 ET | 3878 | 22.06 |
| 10:39 ET | 2630 | 22.1 |
| 10:42 ET | 1636 | 22.07 |
| 10:44 ET | 1951 | 22.1 |
| 10:46 ET | 5323 | 22.01 |
| 10:48 ET | 1300 | 21.93 |
| 10:50 ET | 1800 | 21.8852 |
| 10:51 ET | 1997 | 21.88 |
| 10:53 ET | 2087 | 21.88 |
| 10:55 ET | 500 | 21.87 |
| 10:57 ET | 4470 | 21.81 |
| 11:00 ET | 929 | 21.82 |
| 11:02 ET | 3711 | 21.86 |
| 11:04 ET | 1850 | 21.84 |
| 11:06 ET | 2529 | 21.75 |
| 11:08 ET | 2120 | 21.75 |
| 11:09 ET | 6705 | 21.8 |
| 11:11 ET | 100 | 21.85 |
| 11:13 ET | 991 | 21.81 |
| 11:15 ET | 5358 | 21.75 |
| 11:18 ET | 6707 | 21.77 |
| 11:20 ET | 350 | 21.7886 |
| 11:22 ET | 900 | 21.73 |
| 11:24 ET | 450 | 21.785 |
| 11:26 ET | 16291 | 21.72 |
| 11:27 ET | 3550 | 21.67 |
| 11:29 ET | 2272 | 21.68 |
| 11:31 ET | 632 | 21.664 |
| 11:33 ET | 1891 | 21.65 |
| 11:36 ET | 1000 | 21.64 |
| 11:38 ET | 3493 | 21.6 |
| 11:40 ET | 2184 | 21.605 |
| 11:42 ET | 990 | 21.6 |
| 11:44 ET | 2077 | 21.59 |
| 11:45 ET | 4183 | 21.57 |
| 11:47 ET | 6105 | 21.635 |
| 11:49 ET | 100 | 21.625 |
| 11:51 ET | 3330 | 21.5801 |
| 11:54 ET | 1453 | 21.59 |
| 11:56 ET | 6548 | 21.5927 |
| 11:58 ET | 13804 | 21.55 |
| 12:00 ET | 1310 | 21.57 |
| 12:02 ET | 1339 | 21.51 |
| 12:03 ET | 3196 | 21.5 |
| 12:05 ET | 3946 | 21.48 |
| 12:07 ET | 652 | 21.45 |
| 12:09 ET | 939 | 21.47 |
| 12:12 ET | 1895 | 21.46 |
| 12:14 ET | 2159 | 21.43 |
| 12:16 ET | 2084 | 21.47 |
| 12:18 ET | 1000 | 21.48 |
| 12:20 ET | 2570 | 21.4695 |
| 12:21 ET | 775 | 21.425 |
| 12:23 ET | 6381 | 21.455 |
| 12:25 ET | 3519 | 21.4402 |
| 12:27 ET | 1660 | 21.51 |
| 12:30 ET | 1000 | 21.49 |
| 12:32 ET | 3444 | 21.43 |
| 12:34 ET | 1200 | 21.53 |
| 12:36 ET | 1031 | 21.51 |
| 12:38 ET | 1100 | 21.45 |
| 12:39 ET | 3476 | 21.47 |
| 12:41 ET | 800 | 21.46 |
| 12:43 ET | 3440 | 21.43 |
| 12:45 ET | 4309 | 21.43 |
| 12:48 ET | 1576 | 21.46 |
| 12:50 ET | 2609 | 21.47 |
| 12:52 ET | 439 | 21.48 |
| 12:54 ET | 3943 | 21.45 |
| 12:56 ET | 1900 | 21.475 |
| 12:57 ET | 1804 | 21.475 |
| 12:59 ET | 874 | 21.47 |
| 01:01 ET | 1647 | 21.47 |
| 01:03 ET | 500 | 21.48 |
| 01:06 ET | 3155 | 21.48 |
| 01:08 ET | 2944 | 21.42 |
| 01:10 ET | 3282 | 21.4 |
| 01:12 ET | 1259 | 21.42 |
| 01:14 ET | 2200 | 21.44 |
| 01:15 ET | 697 | 21.44 |
| 01:17 ET | 1908 | 21.44 |
| 01:19 ET | 1774 | 21.42 |
| 01:21 ET | 1800 | 21.43 |
| 01:24 ET | 2084 | 21.46 |
| 01:26 ET | 1209 | 21.47 |
| 01:28 ET | 3027 | 21.55 |
| 01:30 ET | 2427 | 21.54 |
| 01:32 ET | 200 | 21.51 |
| 01:33 ET | 1224 | 21.54 |
| 01:35 ET | 600 | 21.55 |
| 01:37 ET | 2382 | 21.515 |
| 01:39 ET | 2507 | 21.49 |
| 01:42 ET | 3233 | 21.48 |
| 01:44 ET | 400 | 21.455 |
| 01:46 ET | 34681 | 21.51 |
| 01:48 ET | 1601 | 21.505 |
| 01:50 ET | 1596 | 21.53 |
| 01:51 ET | 600 | 21.53 |
| 01:53 ET | 2124 | 21.5284 |
| 01:55 ET | 500 | 21.53 |
| 01:57 ET | 5474 | 21.55 |
| 02:00 ET | 2795 | 21.55 |
| 02:02 ET | 866 | 21.545 |
| 02:04 ET | 2712 | 21.55 |
| 02:06 ET | 1159 | 21.56 |
| 02:08 ET | 1200 | 21.56 |
| 02:09 ET | 7815 | 21.58 |
| 02:11 ET | 9199 | 21.58 |
| 02:13 ET | 21003 | 21.59 |
| 02:15 ET | 12789 | 21.55 |
| 02:18 ET | 309 | 21.565 |
| 02:20 ET | 300 | 21.56 |
| 02:22 ET | 1365 | 21.57 |
| 02:24 ET | 400 | 21.575 |
| 02:26 ET | 450 | 21.58 |
| 02:27 ET | 1804 | 21.58 |
| 02:29 ET | 1754 | 21.56 |
| 02:31 ET | 2473 | 21.5 |
| 02:33 ET | 500 | 21.51 |
| 02:36 ET | 1030 | 21.4895 |
| 02:38 ET | 2196 | 21.4699 |
| 02:40 ET | 3432 | 21.4508 |
| 02:42 ET | 900 | 21.465 |
| 02:44 ET | 4500 | 21.52 |
| 02:45 ET | 300 | 21.52 |
| 02:47 ET | 900 | 21.495 |
| 02:49 ET | 2747 | 21.505 |
| 02:51 ET | 1700 | 21.47 |
| 02:54 ET | 800 | 21.46 |
| 02:56 ET | 2687 | 21.48 |
| 02:58 ET | 3481 | 21.53 |
| 03:00 ET | 500 | 21.53 |
| 03:02 ET | 200 | 21.53 |
| 03:03 ET | 3233 | 21.5 |
| 03:05 ET | 1765 | 21.53 |
| 03:07 ET | 1581 | 21.57 |
| 03:09 ET | 1612 | 21.6 |
| 03:12 ET | 1852 | 21.65 |
| 03:14 ET | 3447 | 21.66 |
| 03:16 ET | 3961 | 21.685 |
| 03:18 ET | 1703 | 21.67 |
| 03:20 ET | 3048 | 21.65 |
| 03:21 ET | 5664 | 21.59 |
| 03:23 ET | 3257 | 21.59 |
| 03:25 ET | 3548 | 21.59 |
| 03:27 ET | 13408 | 21.63 |
| 03:30 ET | 9856 | 21.54 |
| 03:32 ET | 8986 | 21.55 |
| 03:34 ET | 3356 | 21.55 |
| 03:36 ET | 10516 | 21.56 |
| 03:38 ET | 1645 | 21.6 |
| 03:39 ET | 7925 | 21.56 |
| 03:41 ET | 4952 | 21.5906 |
| 03:43 ET | 7768 | 21.64 |
| 03:45 ET | 11410 | 21.59 |
| 03:48 ET | 12661 | 21.49 |
| 03:50 ET | 10330 | 21.4637 |
| 03:52 ET | 39157 | 21.4 |
| 03:54 ET | 18149 | 21.4 |
| 03:56 ET | 19451 | 21.39 |
| 03:57 ET | 39016 | 21.345 |
| 03:59 ET | 51104 | 21.38 |
Today
May 10, 2024
DJ Intellia Therapeutics Is Maintained at Neutral by Citigroup, from 5:44PM ET on Friday May 10, 2024 by Dow Jones
5:44PM ET on Friday May 10, 2024 by Dow JonesDJ Intellia Therapeutics Is Maintained at Outperform by BMO Capital, from 11:18AM ET on Friday May 10, 2024 by Dow Jones
11:18AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones*DJ Intellia Therapeutics 1Q Loss/Shr $1.12 >NTLA, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Intellia Therapeutics Inc | 2.1B | -4.0x | --- |
Agios Pharmaceuticals Inc | 2.1B | -5.8x | --- |
Recursion Pharmaceuticals Inc | 2.0B | -5.1x | --- |
Vera Therapeutics Inc | 2.1B | -18.6x | --- |
Geron Corp | 2.1B | -10.2x | --- |
Celldex Therapeutics Inc | 2.2B | -11.7x | --- |
Company Information
Intellia Therapeutics, Inc. is a clinical-stage genome editing company, which is focused on developing curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) technology. CRISPR/Cas9 is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid. It is focused on leveraging its modular platform to advance in vivo and ex vivo therapies for diseases with high unmet need. Its lead in vivo candidate, NTLA-2001, is for the treatment of transthyretin (ATTR) amyloidosis, as well as NTLA-2002 for the treatment of hereditary angioedema (HAE) are the first CRISPR/Cas9-based therapy candidates to be administered systemically, via intravenous (IV) infusion, for precision editing of a gene in a target tissue in humans. It is also developing ex vivo applications to address immuno-oncology and autoimmune diseases.
Contact Information
- Headquarters
- 40 Erie St Ste 130CAMBRIDGE, MA, United States 02139-4254
- Phone
- 857-285-6200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Frank Verwiel
- President, Chief Executive Officer, Director
- John Leonard
- Chief Financial Officer, Executive Vice President, Treasurer
- Glenn Goddard
- Executive Vice President, Chief Technology Officer
- Eliana Clark
- Executive Vice President, Chief Scientific Officer
- Laura Sepp-Lorenzino
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
|---|---|
Revenue (TTM) | $52.6M |
Shares Outstanding | 96.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.83 |
EPS | $-5.37 |
Book Value | $11.29 |
P/E Ratio | -4.0x |
Price/Sales (TTM) | 39.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -983.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
